https://www.prnewswire.com/news-releases/antengene-enters-into-a-global-clinical-collaboration-with-msd-to-evaluate-atg-037-cd73-inhibitor-in-combination-with-keytruda-pembrolizumab-301709910.html
0
0
12/27/22 at 12:30am
Organization
PRNewswire
40 words
0
Comments
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to...
You are the first to view
Create an account
or login to join the discussion